Liangshuo S. Hu

No. 76, West Yanta Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis.

Hepatic MED1 disruption ameliorates obesity-related fatty liver by attenuating SREBP1-driven lipogenesis.

Journal: Metabolism: clinical and experimental

Published: July 03, 2026

Association of Pre-Transplant Tyrosine Kinase Inhibitor Therapy With Tumor Response and Survival in Hepatocellular Carcinoma: A 10-Year Retrospective Cohort Study of 427 Patients.

Association of Pre-Transplant Tyrosine Kinase Inhibitor Therapy With Tumor Response and Survival in Hepatocellular Carcinoma: A 10-Year Retrospective Cohort Study of 427 Patients.

Journal: World journal of surgery

Published: March 23, 2026

Advances in the treatment and prognosis of intrahepatic cholangiocarcinoma

Advances in the treatment and prognosis of intrahepatic cholangiocarcinoma

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: November 26, 2025

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109.

Metabolic dysfunction-associated steatohepatitis exacerbated by Clostridium perfringens-derived ammonia is attenuated by tripeptide DT-109.

Journal: The Journal of clinical investigation

Published: September 23, 2025

Deep learning-enhanced quantitative evaluation of hepatic ischemia-reperfusion injury and steatosis via near-infrared hyperspectral imaging.

Deep learning-enhanced quantitative evaluation of hepatic ischemia-reperfusion injury and steatosis via near-infrared hyperspectral imaging.

Journal: International journal of surgery (London, England)

Published: June 16, 2025

Epigenetics in metabolic dysfunction-associated steatohepatitis.

Epigenetics in metabolic dysfunction-associated steatohepatitis.

Journal: Cellular signalling

Published: January 09, 2025

Simultaneous Splenic Artery Ligation During Adult Orthotopic Liver Transplantation Improves Surgical Outcomes.

Simultaneous Splenic Artery Ligation During Adult Orthotopic Liver Transplantation Improves Surgical Outcomes.

Journal: World journal of surgery

Published: December 20, 2024

HOPE and AMPK activation reduce reperfusion injury and metabolic dysfunction in primate steatotic liver grafts.

HOPE and AMPK activation reduce reperfusion injury and metabolic dysfunction in primate steatotic liver grafts.

Journal: Scientific reports

Published: October 02, 2024

Response to: Ursodeoxycholic acid and COVID-19 infection in people with liver transplantation.

Response to: Ursodeoxycholic acid and COVID-19 infection in people with liver transplantation.

Journal: QJM : monthly journal of the Association of Physicians

Published: July 17, 2024

Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma.

Site-specific N-glycan alterations on haptoglobin as potential biomarkers for distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma.

Journal: International journal of biological macromolecules

Published: June 05, 2024

Characterization of small RNAs in the spleen of MASH in a non-human primate model.

Characterization of small RNAs in the spleen of MASH in a non-human primate model.

Journal: Genomics

Published: April 06, 2024

Effect of ursodeoxycholic acid on preventing SARS-CoV-2 infection in patients with liver transplantation: a multicenter retrospective cohort study.

Effect of ursodeoxycholic acid on preventing SARS-CoV-2 infection in patients with liver transplantation: a multicenter retrospective cohort study.

Journal: QJM : monthly journal of the Association of Physicians

Published: August 28, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026